References

Click here for links to Additional Resources: Forums, online resources, reviewers, blogs

1. Australian Institute of Health and Welfare. Burden of tobacco use in Australia: Australian Burden of Disease Study 2015. Australian Burden of Disease series no. 21. Cat. no. BOD 20. Canberra: AIHW. 2019
2. Banks E et al. Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Med. 2015
3. Mendelsohn CP. Electronic cigarettes: what can we learn from the UK experience? Med J Aust. 2016
4. Royal Australian College of General Practitioners. Supporting smoking cessation: A guide for health professionals 2021
5. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2019. Drug Statistics series no. 32. PHE 270. Canberra AIHW. 2020
6. West R et al. Smoking Toolkit Study. Smoking in England 2021
7. Caraballo RS et al. Quit Methods Used by US Adult Cigarette Smokers, 2014-2016. Prev Chronic Dis. 2017
8. European Commission. Special Eurobarometer 458. Attitudes of Europeans towards tobacco and electronic cigarettes 2017
9. Hartmann-Boyce J et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021
10. Notley C et al. The unique contribution of e-cigarettes for tobacco harm reduction in supporting smoking relapse prevention. Harm Reduct J. 2018
11. U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioural Basis for Smoking of Attributable Disease. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. 2010
12. Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP 2016
13. International Agency for Research on Cancer. Tobacco smoking and carcinogenic risk to humans. IARC Monograph 100E 2012
14. Benowitz NL et al. Cardiovascular effects of electronic cigarettes. Nat Rev Cardiol. 2017
15. US Department of Health and Human Services. The health consequences of smoking – 50 years of progress. A report of the Surgeon General. 2014
16. Russell C et al. Changing patterns of first e-cigarette flavor used and current flavors used by 20,836 adult frequent e-cigarette users in the USA. Harm Reduct J. 2018
17. Action on Smoking and Health UK. Use of e-cigarettes among young people in Great Britain, 2020 2021
18. Polosa R et al. A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J. 2013
19. Shiffman S et al. Introduction to the Special Issue on JUUL Use. Am J Health Behav. 2021
20. Abrams DB et al. Managing nicotine without smoke to save lives now: Evidence for harm minimization. Prev Med. 2018
21. Nutt DJ et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014
22. Abrams DB et al. Harm Minimization and Tobacco Control: Reframing Societal Views of Nicotine Use to Rapidly Save Lives. Annu Rev Public Health. 2018
23. Therapeutic Goods Administration. Nicotine e-cigarette access 2021
24. New Zealand Ministry of Health. Vaping Facts 2020
25. Australian Institute of Health and Welfare. National Drug Strategy Household Survey (NDSHS) 2016: detailed findings. Drug Statistics series no. 31. Cat. no. PHE 214. Canberra: AIHW 2017
26. Office for National Statistics. Adult smoking habits in the UK: 2019. 2020
27. Ministry of Health New Zealand. New Zealand Health Survey 2019.
28. Dai H et al. Prevalence of e-Cigarette Use Among Adults in the United States, 2014-2018. JAMA. 2019
29. Global State of Tobacco Harm Reduction. Burning Issues 2020
30. Numbeo. Price Rankings by Country of Cigarettes 20 Pack (Marlboro) 2020
31. Wackowski OA et al. Content Analysis of US News Stories About E-Cigarettes in 2015. Nicotine Tob Res. 2018
32. Intergovernmental Committee on Drugs. National Tobacco Strategy 2012-2018. Publications approval number: D1013 2012
33. World Health Organisation. Framework Convention on Tobacco Control (FCTC) 2003
34. Faine G. ABC interview with Jon Faine 2019
35. Yong HH et al. Does the Regulatory Environment for E-Cigarettes Influence the Effectiveness of E-Cigarettes for Smoking Cessation?: Longitudinal Findings From the ITC Four Country Survey. Nicotine Tob Res. 2017
36. Department of Health TGA. Personal Importation Scheme 2015
37. Therapeutic Goods Administration. Nicotine e-cigarettes: Questions and answers 2020
38. Therapeutic Goods Administration. Authorised prescribers 2021
39. Australian Tobacco Harm Reduction Association. The law 2020
40. New Zealand Ministry of Health. Smokefree Environments and Regulated Products Act 1990 – Proposals for regulations 2021
41. Verrall A. New Zealand voices shape vaping regulations. Media release 10 August 2021
42. New Zealand Ministry of Health. Vaping information for stop-smoking services and health workers. 2018
43. Te Hiringa Hauora/Health Promotion Agency. Vape to QuitStrong 2021
44. Australian Tobacco Harm Reduction Association. UK Parliament continues to strongly endorse vaping 2019
45. National Health Service UK. Using e-cigarettes to stop smoking 2019
46. McNeill A et al. Vaping in England: An evidence update including vaping for smoking cessation, February 2021: a report commissioned by Public Health England. London: Public Health England 2021
47. Public Health England. Stoptober 2020 Campaign Resources
48. Steinberg MB et al. Nicotine Risk Misperception Among US Physicians. J Gen Intern Med. 2020
49. Tushingham S et al. Biomolecular archaeology reveals ancient origins of indigenous tobacco smoking in North American Plateau. Proc Natl Acad Sci U S A. 2018
50. Ratsch A et al. The pituri story: a review of the historical literature surrounding traditional Australian Aboriginal use of nicotine in Central Australia. J Ethnobiol Ethnomed. 2010
51. Benowitz NL. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther. 2008
52. National Institute on Drug Abuse. Tolerance, Dependence, Addiction: What’s the Difference? 2017
53. Russell MA. Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J. 1976
54. Royal Society for Public Health. Nicotine no more harmful to health than caffeine 2015
55. McNeill A et al. Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England. London: Public Health England 2018
56. Hartmann-Boyce J et al. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018
57. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009
58. Maina G et al. Transdermal nicotine absorption handling e-cigarette refill liquids. Regul Toxicol Pharmacol. 2016
59. Ramstrom L et al. Patterns of Smoking and Snus Use in Sweden: Implications for Public Health. Int J Environ Res Public Health. 2016
60. Ramstrom L et al. Mortality attributable to tobacco among men in Sweden and other European countries: an analysis of data in a WHO report. Tob Induc Dis. 2014
61. Benowitz NL et al. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009
62. Shiffman S et al. Dependence on e-cigarettes and cigarettes in a cross-sectional study of US adults. Addiction. 2020
63. Hajek P et al. Dependence potential of nicotine replacement treatments: effects of product type, patient characteristics, and cost to user. Prev Med. 2007
64. West R et al. Health-care interventions to promote and assist tobacco cessation: a review of efficacy, effectiveness and affordability for use in national guideline development. Addiction. 2015
65. Mendelsohn C. Optimising nicotine replacement therapy in clinical practice. Aust Fam Physician. 2013
66. Barbeau AM et al. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addict Sci Clin Pract. 2013
67. Bar-Zeev Y et al. Nicotine replacement therapy for smoking cessation during pregnancy. Med J Aust. 2018
68. Claire R et al. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2020
69. Blanc J et al. Nicotine Replacement Therapy during Pregnancy and Child Health Outcomes: A Systematic Review. Int J Environ Res Public Health. 2021
70. Zwar N et al. Nicotine and nicotine replacement therapy – the facts. Australian Pharmacist. 2006
71. Benowitz NL. Nicotine addiction. N Engl J Med. 2010
72. Heishman SJ et al. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl). 2010
73. Morissette SB et al. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol Bull. 2007
74. Tian J et al. The association between quitting smoking and weight gain: a systemic review and meta-analysis of prospective cohort studies. Obes Rev. 2015
75. Glover M et al. Could Vaping be a New Weapon in the Battle of the Bulge? Nicotine Tob Res. 2016
76. Featherstone RE et al. The Role of Nicotine in Schizophrenia. Int Rev Neurobiol. 2015
77. Potter AS et al. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Pharmacol Biochem Behav. 2008
78. Covey LS et al. Anxiety and Depressed Mood Decline Following Smoking Abstinence in Adult Smokers with Attention Deficit Hyperactivity Disorder. J Subst Abuse Treat. 2015
79. Alhowail A. Molecular insights into the benefits of nicotine on memory and cognition (Review). Mol Med Rep. 2021
80. Ma C et al. Nicotine from cigarette smoking and diet and Parkinson disease: a review. Transl Neurodegener. 2017
81. Lunney PC et al. Review article: Ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther. 2012
82. Carstens E E et al. Sensory effects of nicotine and tobacco. Nicotine & Tobacco Research. 2021
83. Goniewicz ML et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014
84. McNeill A et al. E-cigarettes: an evidence update. A report commissioned by Public Health England. PHE publications gateway number: 2015260. 2015
85. National Academies of Sciences Engineering and Medicine. Public health consequences of e-cigarettes. Washington, DC: The National Academies Press 2018
86. Committee on Toxicity of Chemicals in Food Consumer products and the Environment (COT). Statement on the potential toxicological risks from electronic nicotine (and nonnicotine) delivery systems (E(N)NDS – e-cigarettes) 2020
87. Centre for Addiction and Mental Health. Lower-Risk Nicotine Use Guidelines. Funded by Health Canada 2021
88. Health Canada. Vaping and quitting smoking 2021
89. Eissenberg T et al. Invalidity of an Oft-Cited Estimate of the Relative Harms of Electronic Cigarettes. Am J Public Health. 2020
90. Goniewicz ML et al. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes. JAMA Netw Open. 2018
91. George J et al. Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes. J Am Coll Cardiol. 2019
92. Farsalinos K et al. Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes. Intern Emerg Med. 2016
93. Polosa R et al. Persisting long term benefits of smoking abstinence and reduction in asthmatic smokers who have switched to electronic cigarettes. Discov Med. 2016
94. Polosa R et al. COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up. Ther Adv Chronic Dis. 2020
95. Kosmider L et al. Carbonyl compounds in electronic cigarette vapors: effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014
96. Stephens WE. Comparing the cancer potencies of emissions from vapourised nicotine products including e-cigarettes with those of tobacco smoke. Tob Control. 2017
97. McNeill A et al. Underpinning evidence for the estimate that e-cigarette use is around 95% safer than smoking: authors’ note. PHE publications gateway: 2015260 2015.
98. Shahab L et al. Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users: A Cross-sectional Study. Ann Intern Med. 2017
99. Thorne D et al. The mutagenic assessment of an electronic-cigarette and reference cigarette smoke using the Ames assay in strains TA98 and TA100. Mutat Res Genet Toxicol Environ Mutagen. 2016
100. Scungio M et al. Measurements of electronic cigarette-generated particles for the evaluation of lung cancer risk of active and passive users. Journal of Aerosol Science. 2018
101. Benowitz NL et al. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use. Trends Cardiovasc Med. 2016
102. Hubbard R et al. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control. 2005
103. Rostron BL et al. Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysis. Open Heart. 2018
104. Münzel T et al. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. Eur Heart J. 2020
105. Middlekauff HR. Cardiovascular impact of electronic-cigarette use. Trends Cardiovasc Med. 2020
106. Bhatta DN et al. Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health. J Am Heart Assoc. 2019
107. Wills TA et al. E-cigarette use and respiratory disorders: an integrative review of converging evidence from epidemiological and laboratory studies. Eur Respir J. 2021
108. Hajek P et al. A randomised trial of e-cigarettes versus nicotine replacement therapy. N Engl J Med. 2019
109. Farsalinos KE et al. Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health. 2014
110. Polosa R et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health. 2014
111. Miler J et al. Changes in the Frequency of Airway Infections in Smokers Who Switched To Vaping: Results of an Online Survey. Journal of Addiction Research & Therapy. 2016
112. Jose T et al. Electronic Cigarette Use Is Not Associated with COVID-19 Diagnosis. J Prim Care Community Health. 2021
113. Shanks N et al. Are animal models predictive for humans? Philos Ethics Humanit Med. 2009
114. Bhatta DN et al. Association of E-Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis. Am J Prev Med. 2020
115. Kenkel D et al. E-cigarettes and respiratory disease: a replication, extension and future directions. Working Paper 27507 2020
116. Cancer Research UK. Does vaping cause popcorn lung? 2018
117. Siegel M. New Study Finds that Average Diacetyl Exposure from Vaping is 750 Times Lower than from Smoking 2015
118. Australian Government Department of Health. Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO110) Order 2021 (TGO110) 2021
119. Blount BC et al. Vitamin E Acetate in Bronchoalveolar-Lavage Fluid Associated with EVALI. N Engl J Med. 2019
120. Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with E-cigarette Use, or Vaping 2020
121. Hall W et al. Lessons from the public health responses to the US outbreak of vaping-related lung injury. Addiction. 2020
122. St Helen G et al. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction. 2016
123. Martuzevicius D et al. Characterisation of the Spatial and Temporal Dispersion Differences between Exhaled e-cigarette mist and Cigarette Smoke. Nicotine Tob Res. 2018
124. Avino P et al. Second-hand aerosol from tobacco and electronic cigarettes: Evaluation of the smoker emission rates and doses and lung cancer risk of passive smokers and vapers. Sci Total Environ. 2018
125. Levy DT et al. Examining the relationship of vaping to smoking initiation among US youth and young adults: a reality check. Tob Control. 2019
126. The Royal College of Midwives. Position Statement. Support to Quit Smoking in Pregnancy 2019
127. England LJ et al. Adverse pregnancy outcomes in snuff users. Am J Obstet Gynecol. 2003
128. Nardone N et al. JUUL electronic cigarettes: Nicotine exposure and the userexperience. Drug Alcohol Depend. 2019
129. Smith TT et al. Effects of Monoamine Oxidase Inhibition on the Reinforcing Properties of Low-Dose Nicotine. Neuropsychopharmacology. 2016
130. West R et al. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey reveal about high school ecigarette use in the USA? 2019
131. Wylie C et al. Exposures to e-cigarettes and their refills: calls to Australian Poisons Information Centres, 2009–2016. Medical Journal of Australia. 2019
132. Australian Tobacco Harm Reduction Association. Health Minister misinformed about nicotine poisoning 2020
health-minister-misinformed-about-nicotine-poisoning/.
133. Australian Tobacco Harm Reduction Association. Tragic death of child highlights urgent need for liquid nicotine regulation 2020
134. Gummin DD et al. 2018 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 36th Annual Report. Clin Toxicol (Phila). 2019
135. UK Government. e-cigarettes and refill containers (e-liquids): report suspected side effects and safety concerns 2017
136. McFaull SR et al. Injuries and poisonings associated with e-cigarettes and vaping substances, electronic Canadian Hospitals Injury Reporting and Prevention Program, 2011-2019. Health Promot Chronic Dis Prev Can. 2020
137. Scarpino M et al. Brain death following ingestion of E-cigarette liquid nicotine refill solution. Brain Behav. 2020
138. Cairns R et al. Paracetamol poisoning-related hospital admissions and deaths in Australia, 2004-2017. Med J Aust. 2019
139. Hua M et al. Potential health effects of electronic cigarettes: A systematic review of case reports. Prev Med Rep. 2016
140. Vyncke T et al. Injuries associated with electronic nicotine delivery systems: a systematic review. J Trauma Acute Care Surg. 2020
141. Mankowski PJ et al. Cellular phone collateral damage: A review of burns associated with lithium battery powered mobile devices. Burns. 2016
142. Royal College of Physicians TAG. Smoking and health 2021: A coming of age for tobacco control? 2021
143. Lawlor DA et al. Triangulation in aetiological epidemiology. Int J Epidemiol. 2016
144. Walker N et al. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial. Lancet Respir Med. 2019
145. Hartmann-Boyce J et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021
146. Grabovac I et al. Effectiveness of Electronic Cigarettes in Smoking Cessation: a Systematic Review and Meta-Analysis. Nicotine Tob Res. 2020
147. The Joanna Briggs Institute. E–cigarettes for smoking cessation guideline update: technical report of evidence review and summary of findings 2019
148. Chan GCK et al. A systematic review of randomized controlled trials and network meta-analysis of e-cigarettes for smoking cessation. Addict Behav. 2021
149. Banks E et al. Systematic review and meta-analysis of evidence on the efficacy of e-cigarette use for sustained smoking and nicotine cessation. Medrxiv. 2020
150. Pound CM et al. Smoking cessation in individuals who use vaping as compared with traditional nicotine replacement therapies: a systematic review and meta-analysis. BMJ Open. 2021
151. Lee SH et al. Effect of Electronic Cigarettes on Smoking Reduction and Cessation in Korean Male Smokers: A Randomized Controlled Study. J Am Board Fam Med. 2019
152. Wang RJ et al. E-Cigarette Use and Adult Cigarette Smoking Cessation: A Meta-Analysis. Am J Public Health. 2021
153. Berry KM et al. E-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013-2015. Tob Control. 2018
154. Hitchman SC et al. Associations Between E-Cigarette Type, Frequency of Use, and Quitting Smoking: Findings From a Longitudinal Online Panel Survey in Great Britain. Nicotine Tob Res. 2015
155. Phillips CV. Science Lesson: Clinical Trials Are A Terrible Way To Assess Vaping 2017.
156. Thompson A. The Accidental Quitter & Why They Are Important 2019
157. Foulds J et al. Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers with no Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial. MedRxiv. 2021
158. Glasser AM et al. Overview of Electronic Nicotine Delivery Systems: A Systematic Review. Am J Prev Med. 2017
159. Villanti AC et al. How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor. Addiction. 2017
160. Zhu SH et al. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017
161. Johnson L et al. E-cigarette Usage Is Associated With Increased Past-12-Month Quit Attempts and Successful Smoking Cessation in Two US Population-Based Surveys. Nicotine Tob Res. 2018
162. Beard E et al. Association of prevalence of electronic cigarette use with smoking cessation and cigarette consumption in England: a time series analysis between 2006 and 2017. Addiction. 2019
163. Giovenco DP et al. Prevalence of population smoking cessation by electronic cigarette use status in a national sample of recent smokers. Addict Behav. 2017
164. World Vapers’ Alliance. From Smoking to Vaping – Lives Saved 2021
165. Friedman AS. How does electronic cigarette access affect adolescent smoking? J Health Econ. 2015
166. Pesko MF et al. The influence of electronic cigarette age purchasing restrictions on adolescent tobacco and marijuana use. Prev Med. 2016
167. Levy DT et al. US Nicotine Vaping Product SimSmoke Simulation Model: The Effect of Vaping and Tobacco Control Policies on Smoking Prevalence and Smoking-Attributable Deaths. Int J Environ Res Public Health. 2021
168. Levy DT et al. England SimSmoke: The Impact of Nicotine Vaping on Smoking Prevalence and Smoking-Attributable Deaths in England. Addiction. 2020
169. Livingstone-Banks J et al. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev. 2019
170. Notley C et al. Vaping as an alternative to smoking relapse following brief lapse. Drug Alcohol Rev. 2019
171. Morphett K et al. Barriers and facilitators to switching from smoking to vaping: Advice from vapers. Drug Alcohol Rev. 2019
172. Russell C et al. Advice From Former-Smoking E-Cigarette Users to Current Smokers on How to Use E-Cigarettes as Part of an Attempt to Quit Smoking. Nicotine Tob Res. 2018
173. Ward E et al. A Qualitative Exploration of the Role of Vape Shop Environments in Supporting Smoking Abstinence. Int J Environ Res Public Health. 2018
174. Polosa R et al. Quit and smoking reduction rates in vape shop consumers: a prospective 12-month survey. Int J Environ Res Public Health. 2015
175. Wagener TL et al. Examining the Smoking and Vaping Behaviors and Preferences of Vape Shop Customers. Tobacco Prevention & Cessation. 2016
176. Gravely S et al. Discussions between health professionals and smokers about nicotine vaping products: results from the 2016 ITC Four Country Smoking and Vaping Survey. Addiction. 2019
177. Erku DA et al. Beliefs and Self-reported Practices of Health Care Professionals Regarding Electronic Nicotine Delivery Systems: A Mixed-Methods Systematic Review and Synthesis. Nicotine Tob Res. 2020
178. Cancer Research UK. Headlines saying ‘vaping might cause cancer’ are wildly misleading 2018
179. Cancer Research UK. 6 tips to spot cancer ‘fake news’ 2018
180. Kosmider L et al. Compensatory puffing with lower nicotine concentration e-liquids increases carbonyl exposure in e-cigarette aerosols Nicotine Tob Res. 2017
181. Prochaska JJ et al. Nicotine delivery and cigarette equivalents from vaping a JUULpod. Tob Control. 2021
182. Goldenson NI et al. Switching away from Cigarettes across 12 Months among Adult Smokers Purchasing the JUUL System. Am J Health Behav. 2021
183. Heatherton TF et al. Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict. 1989
184. Hajek P et al. Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products. Addiction. 2020
185. Bertrand P et al. Physical and chemical assessment of 1,3 Propanediol as a potential substitute of propylene glycol in refill liquid for electronic cigarettes. Sci Rep. 2018
186. Benowitz NL et al. Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame. J Clin Pharmacol. 2021
187. Glasser A et al. Patterns of e-cigarette use and subsequent cigarette smoking cessation over two years (2013/2014 to 2015/2016) in the Population Assessment of Tobacco and Health (PATH) Study. Nicotine Tob Res. 2020
188. Landry RL et al. The role of flavors in vaping initiation and satisfaction among U.S. adults. Addict Behav. 2019
189. Gendall P et al. Role of flavours in vaping uptake and cessation among New Zealand smokers and non-smokers: a cross-sectional study. Tob Control. 2020
190. Kreiss K et al. Clinical bronchiolitis obliterans in workers at a microwave-popcorn plant. N Engl J Med. 2002
191. Behar RZ et al. Distribution, quantification and toxicity of cinnamaldehyde in electronic cigarette refill fluids and aerosols. Tob Control. 2016
192. Kosmider L et al. Cherry-flavoured electronic cigarettes expose users to the inhalation irritant, benzaldehyde. Thorax. 2016
193. Scientific Committee on Health Environmental and Emerging Risks (SCHEER). Opinion on electronic cigarettes 2021
194. NSW Health. RETAILER FACTSHEET. Ban on display of tobacco, smoking and e-cigarette products in retail outlets 2017
195. Roberts C. The End Of Mail-Order JUUL. Forbes.com 2021
196. Therapeutic Goods Administration. Nicotine e-cigarettes: Information for prescribers 2021
197. Australian Government. Customs Act 1901 2020
198. Therapeutic Goods Administration. Traveller’s exemption 2020
199. Kimber CF et al. Changes in puffing topography and subjective effects over a 2-week period in e-cigarette naïve smokers: Effects of device type and nicotine concentrations. Addict Behav. 2021
200. Farsalinos KE et al. Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naive users (smokers). Sci Rep. 2015
201. St Helen G et al. Nicotine Delivery and Vaping Behavior During ad Libitum E-cigarette Access. Tob Regul Sci. 2016
202. Hajek P et al. Nicotine intake from electronic cigarettes on initial use and after 4 weeks of regular use. Nicotine Tob Res. 2015
203. Briganti M et al. Bibliometric Analysis of Electronic Cigarette Publications: 2003⁻2018. Int J Environ Res Public Health. 2019
204. Wodak A. Hysteria about drugs and harm minimisation. It’s always the same old story.2016
205. Balfour DJK et al. Balancing Consideration of the Risks and Benefits of E-Cigarettes. Am J Public Health. 2021
206. Guerin N et al. ASSAD 2017 Statistics & Trends: Australian Secondary Students’ Use of Tobacco, Alcohol, Over-the-counter Drugs, and Illicit Substances. Cancer Council Victoria. 2018
207. ASH New Zealand. ASH Year 10 Snapshot 2018
208. Bauld L et al. E-Cigarette Uptake Amongst UK Youth: Experimentation, but Little or No Regular Use in Nonsmokers. Nicotine Tob Res. 2016
209. Glasser AM et al. Youth Vaping and Tobacco Use in Context in the United States: Results from the 2018 National Youth Tobacco Survey. Nicotine Tob Res. 2020
210. de Lacy E et al. Cross-sectional study examining the prevalence, correlates and sequencing of electronic cigarette and tobacco use among 11-16-year olds in schools in Wales. BMJ Open. 2017
211. Jarvis M et al. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey 2017-2019 reveal about high school e-cigarette use in the USA? Qeios 2020
212. Mendelsohn CP et al. Does the gateway theory justify a ban on nicotine vaping in Australia? Int J Drug Policy. 2020
213. Soneji S et al. Association Between Initial Use of e-Cigarettes and Subsequent Cigarette Smoking Among Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017
214. Vanyukov MM et al. Common liability to addiction and “gateway hypothesis”: theoretical, empirical and evolutionary perspective. Drug Alcohol Depend. 2012
215. Rigsby DC et al. Electronic Vapor Product Usage and Substance Use Risk Behaviors Among U.S. High School Students. J Child Adolesc Psychopharmacol. 2019
216. Khouja JN et al. Association of genetic liability to smoking initiation with e-cigarette use in young adults: A cohort study. PLoS Med. 2021
217. Hall W et al. The “gateway” effect of e-cigarettes may be explained by a genetic liability to risk-taking. PLoS Med. 2021
218. New Zealand Government. New vaping to quit smoking website launches 2019
219. Kozlowski LT et al. Adolescents and e-cigarettes: Objects of concern may appear larger than they are. Drug Alcohol Depend. 2017
220. Chan GCK et al. Gateway or common liability? A systematic review and meta-analysis of studies of adolescent e-cigarette use and future smoking initiation. Addiction. 2020
221. Kozlowski LT et al. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction. BMC Public Health. 2016
222. Selya AS et al. Trends in electronic cigarette use and conventional smoking: quantifying a possible ‘diversion’ effect among US adolescents. Addiction. 2021
223. Foxon F et al. Electronic cigarettes, nicotine use trends and use initiation ages among US adolescents from 1999 to 2018. Addiction. 2020
224. Friedman AS et al. Associations of Flavored e-Cigarette Uptake With Subsequent Smoking Initiation and Cessation. JAMA Netw Open. 2020
225. Wang TW et al. Tobacco Product Use and Associated Factors Among Middle and High School Students – United States, 2019. Morbidity and mortality weekly report Surveillance summaries (Washington, DC : 2002). 2019
226. Sun T et al. Has increased youth e-cigarette use in the USA, between 2014 and 2020, changed conventional smoking behaviors, future intentions to smoke and perceived smoking harms? Addict Behav. 2021
227. Walker N et al. Use of e-cigarettes and smoked tobacco in youth aged 14-15 years in New Zealand: findings from repeated cross-sectional studies (2014-19). Lancet Public Health. 2020
228. Sokol NA et al. High school seniors who used e-cigarettes may have otherwise been cigarette smokers: Evidence from Monitoring the Future (United States, 2009-2018). Nicotine Tob Res. 2021
229. Shahab L et al. Association of initial e-cigarette and other tobacco product use with subsequent cigarette smoking in adolescents: a cross-sectional, matched control study. Tob Control. 2020
230. Action on Smoking and Health UK. Use of e-cigarettes among young people in Great Britain 2019.
231. Miech R et al. What are kids vaping? Results from a national survey of US adolescents. Tob Control. 2017
232. Tokle R et al. Adolescents’ use of nicotine-free and nicotine e-cigarettes: A longitudinal study of vaping transitions and vaper characteristics. Nicotine Tob Res. 2021
233. Jackson SE et al. Dependence on nicotine in US high school students in the context of changing patterns of tobacco product use. Addiction. 2021
234. Yuan M et al. Nicotine and the adolescent brain. J Physiol. 2015
235. US Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General, Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2016
236. Jha P et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013
237. Wang TW et al. Tobacco Product Use and Associated Factors Among Middle and High School Students – United States, 2019: Centers for Disease Control and Prevention; 2019. 1-22
238. Park-Lee E et al. Notes from the Field: E-cigarette use among middle and high school students. National Youth Tobacco Survey US. MMWR Morb Mortal Wkly Rep 2021
239. National Drug and Alcohol Research Centre – University of New South Wales. Alcohol and Young People 2016
240. Kozlowski LT. Policy Makers and Consumers Should Prioritize Human Rights to Being Smoke-Free Over Either Tobacco- or Nicotine-Free: Accurate Terms and Relevant Evidence. Nicotine Tob Res. 2020
241. Baicker K et al. Evidence-Based Health Policy. N Engl J Med. 2017
242. Erku DA et al. Policy Debates Regarding Nicotine Vaping Products in Australia: A Qualitative Analysis of Submissions to a Government Inquiry from Health and Medical Organisations. Int J Environ Res Public Health. 2019
243. House of Representatives Standing Committee on Health Aged Care and Sport. Use and marketing of electronic cigarettes and personal vaporisers in Australia. Hansard 5 October 2017 2017
244. New Zealand Ministry of Health. Position Statement on Vaping 2020
245. Saebo G et al. Assessing notions of denormalization and renormalization of smoking in light of e-cigarette regulation. Int J Drug Policy. 2017
246. Action on Smoking and Health UK. Use of electronic cigarettes (vapourisers) among adults in Great Britain. 2018
247. European Commission. Communication on the precautionary principle. Brussels, 2.2.2000 (COM(2000) final. 2000
248. Morphett K et al. The misuse of the precautionary principle in justifying Australia’s ban on the sale of nicotine vaping products. Nicotine Tob Res. 2020
249. Mendez D et al. A magic bullet? The potential impact of e-cigarettes on the toll of cigarette smoking. Nicotine Tob Res. 2020
250. Petrovic-van der Deen FS et al. Potential Country-level Health and Cost Impacts of Legalizing Domestic Sale of Vaporized Nicotine Products. Epidemiology. 2019
251. Levy DT et al. Potential deaths averted in USA by replacing cigarettes with e-cigarettes. Tob Control. 2017
252. Kotz D et al. The Use of Tobacco, E-Cigarettes, and Methods to Quit Smoking in Germany. Dtsch Arztebl Int. 2018
253. Kyzer L. Vaping Linked to Decrease in Cigarette Smoking. Iceland Review. 2018
254. Farsalinos KE et al. Electronic cigarette use in Greece: an analysis of a representative population sample in Attica prefecture. Harm Reduct J. 2018
255. Oakly A et al. Dual use of electronic cigarettes and tobacco in New Zealand from a nationally representative sample. Aust N Z J Public Health. 2019
256. Farsalinos KE et al. Electronic cigarette use in the European Union: analysis of a representative sample of 27 460 Europeans from 28 countries. Addiction. 2016
257. Selya AS et al. Dual Use of Cigarettes and JUUL: Trajectory and Cigarette Consumption. Am J Health Behav. 2021
258. Martinez U et al. Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial. Lancet Public Health. 2021
259. Brown J et al. Prevalence and characteristics of e-cigarette users in Great Britain: Findings from a general population survey of smokers. Addict Behav. 2014
260. Liu G et al. A comparison of nicotine dependence among exclusive E-cigarette and cigarette users in the PATH study. Prev Med. 2017
261. Piper ME et al. Changes in Use Patterns Over 1 Year Among Smokers and Dual Users of Combustible and Electronic Cigarettes. Nicotine Tob Res. 2020
262. Action on Smoking and Health UK. Use of e-cigarettes (vapes) among adults in Great Britain 2021
263. Owusu D et al. Patterns and trends of dual use of e-cigarettes and cigarettes among U.S. adults, 2015-2018. Prev Med Rep. 2019
264. Arnold MJ et al. Harm reduction associated with dual use of cigarettes and e-cigarettes in Black and Latino smokers: Secondary analyses from a randomized controlled e-cigarette switching trial. Nicotine Tob Res. 2021
265. McRobbie H et al. Effects of Switching to Electronic Cigarettes with and without Concurrent Smoking on Exposure to Nicotine, Carbon Monoxide, and Acrolein. Cancer Prev Res (Phila). 2015
266. Borland R et al. A new classification system for describing concurrent use of nicotine vaping products alongside cigarettes (so-called ‘dual use’): findings from the ITC-4 Country Smoking and Vaping wave 1 Survey. Addiction. 2019
267. Kotz D et al. ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction. 2014
268. Imperial Brands. Share price 2021
269. Philip Morris International. 2021 Second-Quarter Results 2021
270. Action on Smoking and Health UK. Use of e-cigarettes (vapes) among adults in Great Britain 2020
271. Malt L et al. Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data. Harm Reduct J. 2020
272. Erku DA et al. Framing and scientific uncertainty in nicotine vaping product regulation: An examination of competing narratives among health and medical organisations in the UK, Australia and New Zealand. Int J Drug Policy. 2020
273. Kahneman D. Thinking, Fast and Slow: Penguin UK; 2012
274. Paek H. Risk Perceptions and Risk Characteristics. Oxford Research Encyclopedias 2017
275. Ropeik D. The perception gap: An explanation for why people maintain irrational fears. Scientific American 2011 
276. Bates C. The critic’s guide to bad vaping science. The Counterfactual 2016
277. Haidt J. The Righteous Mind: Why Good People are Divided by Politics and Religion: Penguin Press; 2013.
278. Kozlowski LT. Minors, Moral Psychology, and the Harm Reduction Debate: The Case of Tobacco and Nicotine. J Health Polit Policy Law. 2017
279. Noor I. Confirmation Bias. SimplyPsychology 2020
280. Swire-Thompson B et al. Searching for the Backfire Effect: Measurement and Design Considerations. J Appl Res Mem Cogn. 2020
281. Lord CG et al. Biased Assimilation and attitude polarization: The effects of prior theories on subsequently considered evidence. Journal of Personality and Social Psychology. 1979
282. Munafò MR et al. E-cigarette research needs to adopt open science practices to improve quality. Addiction. 2020
283. Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can’t quit. A report by the Tobacco Advisory Group of the Royal College of Physicians. London: RCP: Royal College of Physicians; 2007
284. National Institute for Health and Care Excellence. Smoking: harm reduction 2013
285. Royal College of Physicians. RCP statement on e-cigarettes 2014
286. Australian Government Department of Health. National Drug Strategy 2017-2026. 2017
287. Redmond H. The war on nicotine pits prejudice against Public Health. Filter magazine 2018
288. Warner KE. How to Think – Not Feel – about Tobacco Harm Reduction. Nicotine Tob Res. 2018
289. MacCoun RJ. Moral Outrage and Opposition to Harm Reduction. Crim Law and Philos. 2012
290. McDonald CF et al. Electronic cigarettes: A position statement from the Thoracic Society of Australia and New Zealand. Respirology. 2020
291. Bates C. Understanding the war on vaping. In: The Tobacco Reporter. 2021
292. Mendelsohn CP. How opponents of vaping aid and abet Big Tobacco. The Spectator 2019
293. Phillips CV. Why is there anti-THR? (3) Anti-tobacco extremism 2015
294. Phillips CV. Why is there anti-THR? “Not Invented Here” syndrome 2015
295. Sutherland R. Alchemy: The Surprising Power of Ideas That Don’t Make Sense: WH Allen; 2019.
296. Tyndall M. Twitter post on tobacco control advocates and vaping 2021
297. Newman J. Evidence-based policy or risk minimisation? The regulation of e-cigarettes in Australia. Evidence & Policy. 2019
298. Allsop S. Swimming with crocodiles: Lessons learned from 40 years of trying to influence policy 2020
299. Psychology Today. Groupthink 2019
300. Kahan DM. Why Smart People Are Vulnerable to Putting Tribe Before Truth. Scientific American blog 2018
301. Juma C. Innovation and Its Enemies: Why People Resist New Technologies: Oxford University Press; 2016.
302. Commonwealth of Australia. Budget Strategy and Outlook Budget Paper No. 1, 2019-20 2020
303. Phillips CV. Why is there anti-THR? (4) Money, money, money 2015
304. Mendelsohn CP. Tobacco tax rise exploits and punishes addicted smokers. news.com.
au. 2017
305. Public Health Law Centre – Mitchell Hamline School of Law. The Master Settlement: an overview 2019
306. Bates C. Holding the Bloomberg anti-vaping propaganda complex to account. The Counterfactual 2021
307. Oreskes N et al. Merchants of Doubt: Bloomsbury Press; 2010.
308. Brown and Williamson. Smoking and Health Proposal. Truth Tobacco Industry Documents. 1969
309. Australian Tobacco Harm Reduction Association. An update on the lung disease
outbreak in the US 2019
310. Australian Government Department of Health. E-cigarettes linked to severe lung illness 2019
311. Australian Tobacco Harm Reduction Association. Government officials misleading the
Australian public on vaping needs to end 2019
312. Knott M. “Canary in the coal mine”: US e-cigarette lung disease epidemic a worry: expert 2019
313. Tattan-Birch H et al. Association of the US Outbreak of Vaping-Associated Lung Injury With Perceived Harm of e-Cigarettes Compared With Cigarettes. JAMA Netw Open. 2020
314. Dave MD et al. News that takes your breath away: risk perceptions during an outbreak of vaping-related lung injuries. NBER Working Paper Series 2020
315. Redmond H. Anti-Vaping Zealots Find Opportunity in the Pandemic. Filter 2020
316. Victoria State Government Health and Human Services. Smoking and e-cigarette use. Coronavirus (COVID-19) 2020
317. Gaiha SM et al. Association Between Youth Smoking, Electronic Cigarette Use, and COVID-19. J Adolesc Health. 2020
318. Channel 7 news. Young vapers more likely to get COVID-19 20203
319. Bates C. Devastating post-publication peer reviews but the paper, PR and politics remain untouched. Pubpeer 2020
320. Farsalinos K et al. E-Cigarette Use and COVID-19: Questioning Data Reliability. J Adolesc Health. 2021
321. Kale D et al. Associations between vaping and Covid-19: Cross-sectional findings from the HEBECO study. Drug Alcohol Depend. 2021
322. Sussman RA et al. Aerial Transmission of the SARS-CoV-2 Virus through Environmental E-Cigarette Aerosols: Implications for Public Policies. Int J Environ Res Public Health. 2021
323. Chen J et al. A Comparative Health Risk Assessment of Electronic Cigarettes and Conventional Cigarettes. Int J Environ Res Public Health. 2017
324. McKee M et al. E-cigarettes should be regulated. Med J Aust. 2016
325. Hall B. Vaping likely to be banned in Melbourne CBD’s smoke-free zones. In The Age. 2020
326. Chapman S. Twelve myths about e-cigarettes that failed to impress the TGA. The Conversation. 2017
327. Chapman S et al. Submission to The Standing Committee on Health, Aged Care and Sport on Electronic Cigarettes and Vapourisers. (Submission 313) 2017
328. Public Health England. A note of errors concerning the UK in previous evidence submissions to the Committee 2017
329. Creighton A. Health trio accused of presenting ‘factual errors’ to e cig inquiry. The Weekend Australian 2017
330. Chapman S et al. Public Submission to the Senate Select Committee on Tobacco Harm Reduction. Submission 195 2020
331. McNeill A. Additional Comment to the Australian Select Committee on Tobacco Harm Reduction. Response to submission 195 2020
332. Brooke M. Talking Point: Vaping can hook a new generation. In the Mercury, Tasmania (print edition) 29 February 2020.
333. Australian Tobacco Harm Reduction Association. Lung Foundation Australia claims vaping as harmful as smoking 2020
334. Australian Tobacco Harm Reduction Association. Lung Foundation Australia continues to mislead the public about vaping 2020
335. Australian Tobacco Harm Reduction Association. Cancer Council Australia and Heart Foundation misinformed on vaping 2020
336. ABC Sunshine Coast. Interview with AMA President, Dr Tony Bartone 2018
337. 6PR Radio Station. Interview with AMA President, Dr Omar Khorshid 2018
338. Australian Tobacco Harm Reduction Association. It is legal to import nicotine into Queensland. 2018
339. Australian Tobacco Harm Reduction Association. Queensland Health caught out in vaping bungle … again. 2019
340. Mendelsohn C. Prohibition and Misinformation: Australia’s Tobacco Harm Reduction Fail. Filter magazine 2019
341. Australian Tobacco Harm Reduction Association. ATHRA in strong disagreement with Andrew Forrest. 2018
342. McCauley D. Vaping: a harmless alternative, or a dangerous gateway to smoking? Sydney Morning Herald and The Age. 2020
343. Han E. Secret industry funding of doctor-led vaping lobby group laid bare. Sydney Morning Herald. 2018
344. Smith R. Time to assume that health research is fraudulent until proven otherwise? Blog: British Medical Journal. 2021
345. Rodu B. NIH Funding Stifles Tobacco Harm Reduction Research and Support in Academia. In Tobacco Truth blog. 2015
346. Gunther M. Here Comes Trouble: An Anti-Tobacco Hero’s Complicated Legacy. In Undark. 2021
347. Retraction to: Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health. J Am Heart Assoc. 2020
348. Britton AR. Vaping and lung disease. The Times 2019
349. Jensen RP et al. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015
350. Farsalinos KE et al. E-cigarettes emit very high formaldehyde levels only in conditions that are aversive to users: A replication study under verified realistic use conditions. Food Chem Toxicol. 2017
351. Allen JG et al. Flavoring Chemicals in E-Cigarettes: Diacetyl, 2,3-Pentanedione, and Acetoin in a Sample of 51 Products, Including Fruit-, Candy-, and Cocktail-Flavored E-Cigarettes. Environ Health Perspect. 2016
352. Chivers E et al. Nicotine and other potentially harmful compounds in “nicotine‐free” e‐cigarette liquids in Australia. Medical Journal of Australia. 2019
353. The Logic of Science. 5 simple chemistry facts that everyone should understand before talking about science 2015
354. Ames BN et al. The causes and prevention of cancer: gaining perspective. Environ Health Perspect. 1997
355. Vlachopoulos C et al. Electronic Cigarette Smoking Increases Aortic Stiffness and Blood Pressure in Young Smokers. J Am Coll Cardiol. 2016
356. Science Media Centre U. Expert reaction to three conference papers on e-cigarettes 2017
357. Borwein J et al. Clearing up confusion between correlation and causation. The Conversation 2014
358. Alzahrani T et al. Association Between Electronic Cigarette Use and Myocardial Infarction. Am J Prev Med. 2018
359. Critcher CR et al. Re-examining the Association Between E-Cigarette Use and Myocardial Infarction: A Cautionary Tale. Am J Prev Med. 2021
360. Bonn SA. Moral panic: who benefits from public fear.Psychology Today 2015
361. Boeri M. Re-criminalizing cannabis is worse than 1930s ‘reefer madness’. In: The Conversation. 2018
362. Hansen J. Deadly warning over teens’ obsession with vaping. Daily Telegraph. 2021
363. Benowitz NL. Seizures After Vaping Nicotine in Youth: A Canary or a Red Herring? J
Adolesc Health. 2020
364. AOD Media Watch. Demonising vaping: The Tele and APC threaten public health. 2021
365. Paine H. Sydney teen issues vape warning after being hospitalised. Daily Telegraph 2021
366. Mendelsohn CP. Misinformation about vaping will keep adults smoking. In Alcohol and Other Drugs Media Watch 2021
367. Therapeutic Goods Administration. Poisons Standard June 2021 (SUSMP no.22). Federal Department of Health 2021
368. World Health Organisation. Constitution of the World Health Organisation 1946
369. United Nations. Universal Declaration of Human Rights 1948
370. Global Commission on Drug Policy. War on drugs. Report. 2011
371. Volkow ND et al. Drug use disorders: impact of a public health rather than a criminal justice approach. World Psychiatry. 2017
372. Parliament of Victoria. Law Reform Road and Community Safety Committee. Inquiry ito drug law reform 2018
373. Wikipedia. Harm Principle 2021
374. Hutcheon S et al. Smoke and mirrors: The nanny state critics behind the vape debate. ABC Background Briefing. 2019
375. Clarke P et al. Mortality by Commonwealth Electoral Divisions in Australia. Public Health Information Development Unit, Torrens University Australia and Centre for Health Policy, University of Melbourne 2016
376. Bonevski B et al. No smoker left behind: it’s time to tackle tobacco in Australian priority populations. Med J Aust. 2018
377. Marmot M et al. Fair Society Healthy Lives 2010
378. Giovenco DP. Different Smokes for Different Folks? E-Cigarettes and Tobacco Disparities. Am J Public Health. 2019
379. Brown J et al. Quit success rates in England 2007-2017. Smoking in Britain. 2017
380. Kock L et al. E-cigarette use in England 2014-17 as a function of socio-economic profile. Addiction. 2018
381. Thirlway F et al. Tobacco smoking and vulnerable groups: Overcoming the barriers to harm reduction. Addict Behav. 2019
382. Twyman L et al. Electronic Cigarettes: Awareness, Recent Use, and Attitudes Within a Sample of Socioeconomically Disadvantaged Australian Smokers. Nicotine Tob Res. 2016
383. Gartner C. The potential impact of vaporized nicotine products on vulnerable subpopulations. Addiction. 2016
384. Pulvers K et al. Effect of Pod e-Cigarettes vs Cigarettes on Carcinogen Exposure Among African American and Latinx Smokers: A Randomized Clinical Trial. JAMA Netw Open. 2020
385. Brose LS et al. Mental health and smoking cessation-a population survey in England. BMC Med. 2020
386. Hoek J et al. A qualitative analysis of low income smokers’ responses to tobacco excise tax increases. Int J Drug Policy. 2016
387. Bates C. The principle of proportionality The Tobacco Reporter 2019
388. Magnusson RS. Time to raise the minimum purchasing age for tobacco in Australia. Med J Aust. 2016
389. Leventhal AM et al. Flavored E-cigarette Use and Progression of Vaping in Adolescents. Pediatrics. 2019
390. Wellman RJ et al. Predictors of the Onset of Cigarette Smoking: A Systematic Review of Longitudinal Population-Based Studies in Youth. Am J Prev Med. 2016
391. Buckell J et al. Should flavours be banned in cigarettes and e-cigarettes? Evidence on adult smokers and recent quitters from a discrete choice experiment. Tob Control. 2018
392. Friedman AS. A Difference-in-Differences Analysis of Youth Smoking and a Ban on Sales of Flavored Tobacco Products in San Francisco, California. JAMA Pediatr. 2021
393. Liber A et al. Flavored E-Cigarette Sales in the United States Under Self-Regulation From January 2015 Through October 2019. Am J Public Health. 2020
394. European Tobacco Harm Reduction Advocates (ETHRA). The EU Nicotine Users Survey
2020. The EU residents report 2021. Available from:
395. Posner H et al. Reactions to sales restrictions on flavored vape products or all vape products among young adults in the US. Nicotine Tob Res. 2021
396. Aslani A et al. Design, formulation and evaluation of nicotine chewing gum. Adv Biomed Res. 2012
397. Karasz P. Two UK Hospitals Allow Vape Shops in Bid to Promote Smoking Ban. The New York Times 2019
398. Burstyn I. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health. 2014
399. Public Health England. Use of e-cigarettes in public places and workplaces. Advice to inform evidence-based policy making. PHE publications gateway number: 2016129 2016
400. The Royal Australian & New Zealand College of Psychiatrists. E-cigarettes and vaporisers. Position statement 97 2018
401. Dave D et al. Does e-cigarette advertising encourage adult smokers to quit? J Health Econ. 2019
402. UK Advertising Code. UK Code of Non-Broadcast Advertising 2016
403. Jawad M et al. Price elasticity of demand of non-cigarette tobacco products: a systematic review and meta-analysis. Tob Control. 2018
404. Gorini G et al. The Regulatory Environment and Cost of Electronic Cigarettes in Italy, 2014-2015, Influenced their Use for Quitting. Nicotine Tob Res. 2018
405. Saffer H et al. E-cigarettes and adult smoking: evidence from Minnesota. National Bureau of Economic Research 2019
406. Pesko MF et al. The Effect of Prices on Youth Cigarette and E-cigarette Use: Economic Substitutes or Complements? National Bureau of Economic Research 2017
407. Medicines and Healthcare products Regulatory Agency UG. Yellow Card Scheme 2021
408. Australian Tobacco Harm Reduction Association. Regulation of nicotine e-liquids for vaping in Australia 2020
409. Bonokoski M. Health Canada coughs up counterintuitive vape policy. Toronto Sun 2021.
410. Wikipedia. Social movement 2021
411. Australian Tobacco Harm Reduction Association. Australia’s ban on nicotine importation lifted…for now 2020
412. District Court of Wellington. Ministry of Health v Phillip Morris (New Zealand) Limited. Judgement of Judge PJ Butler
413. Quebec Superior Court. Quebec Vaping Association vs Attorney General of Quebec 2019
414. Federal Office of Public Health Switzerland. Lifting of the ban on the sale of snus 2019.
415. Planck MK. Planck’s principle. In: Wikipedia
416. Australian Tobacco Harm Reduction Association. Australian and New Zealand medical specialists announce support for vaping. 2020
417. British Medical Association. E-cigarettes: Balancing risks and opportuities. 2017
418. Academie Nationale de Medicine. Vaping nicotine 2019
419. Thomas KH, Dalili MN, López-López JA, et al. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess 2021; 25 (59): 1-224 2021/10/21
420. Rauch J. The Constitution of Knowledge: A defense of Truth: Brookings Institution; 2021